These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29293665)

  • 1. Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    Hadjialirezaei S; Picco G; Beatson R; Burchell J; Stokke BT; Sletmoen M
    PLoS One; 2018; 13(1):e0190814. PubMed ID: 29293665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
    Goode G; Gunda V; Chaika NV; Purohit V; Yu F; Singh PK
    PLoS One; 2017; 12(6):e0179098. PubMed ID: 28570622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: A minimally invasive optical trapping system to understand cellular interactions at onset of an immune response.
    Glass DG; McAlinden N; Millington OR; Wright AJ
    PLoS One; 2018; 13(4):e0196266. PubMed ID: 29664948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2016; 11(9):e0162936. PubMed ID: 27607428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction: Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.
    Wulaningsih W; Holmberg L; Abeler-Dörner L; Ng T; Rohrmann S; Van Hemelrijck M
    PLoS One; 2016; 11(8):e0161418. PubMed ID: 27512987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: breast cancer screening in Saudi Arabia: free but almost no takers.
    PLOS ONE Staff
    PLoS One; 2015; 10(4):e0124850. PubMed ID: 25853811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: galectin-3 as a marker and potential therapeutic target in breast cancer.
    PLOS ONE Staff
    PLoS One; 2015; 10(1):e0116994. PubMed ID: 25621883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: HP1β is a biomarker for breast cancer prognosis and PARP inhibitor therapy.
    Lee YH; Liu X; Qiu F; O'Connor TR; Yen Y; Ann DK
    PLoS One; 2015; 10(4):e0124853. PubMed ID: 25875848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
    PLoS One; 2018; 13(1):e0191579. PubMed ID: 29342211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
    Korkola JE; Collisson EA; Heiser LM; Oates C; Bayani N; Itani S; Esch A; Thompson W; Griffith OL; Wang NJ; Kuo WL; Cooper B; Billig J; Ziyad S; Hung JL; Jakkula L; Feiler H; Lu Y; Mills GB; Spellman PT; Tomlin C; Mukherjee S; Gray JW
    PLoS One; 2017; 12(10):e0186551. PubMed ID: 29020035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    Bromberg SE; Moraes PRAF; Ades F
    PLoS One; 2018; 13(3):e0195130. PubMed ID: 29579107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Optical imaging of ovarian cancer using a matrix metalloproteinase-3-sensitive near-infrared fluorescent probe.
    Wang KH; Wang YM; Chiu LH; Chen TC; Tsai YH; Zuo CS; Chen KC; Changou CA; Lai WT
    PLoS One; 2018; 13(8):e0202610. PubMed ID: 30107000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucins (MUC1 and MUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation.
    Cao Y; Blohm D; Ghadimi BM; Stosiek P; Xing PX; Karsten U
    J Histochem Cytochem; 1997 Nov; 45(11):1547-57. PubMed ID: 9358856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: chemobrain experienced by breast cancer survivors: a meta-ethnography study investigating research and care implications.
    PLOS ONE Staff
    PLoS One; 2015; 10(2):e0117740. PubMed ID: 25647507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    Haraldsdottir A; Torfadottir JE; Valdimarsdottir UA; Adami HO; Aspelund T; Tryggvadottir L; Thordardottir M; Birgisdottir BE; Harris TB; Launer LJ; Gudnason V; Steingrimsdottir L
    PLoS One; 2018; 13(10):e0206026. PubMed ID: 30321233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
    PLOS ONE Staff
    PLoS One; 2017; 12(3):e0174493. PubMed ID: 28301577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    Bradford JR; Cox A; Bernard P; Camp NJ
    PLoS One; 2018; 13(2):e0192589. PubMed ID: 29408913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    Syed BM; Morgan D; Setty T; Green AR; Paish EC; Ellis IO; Cheung KL
    PLoS One; 2018; 13(1):e0191979. PubMed ID: 29370282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: 3, 3'5 Triiodo L Thyronine Induces Apoptosis in Human Breast Cancer MCF-7cells, Repressing SMP30 Expression through Negative Thyroid Response Elements.
    Sar P; Peter R; Rath B; Mohapatra AD; Mishra SK
    PLoS One; 2013; 8(6):. PubMed ID: 29294469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
    Bonsang-Kitzis H; Chaltier L; Belin L; Savignoni A; Rouzier R; Hamy AS; Sablin MP; Lerebours F; Bidard FC; Cottu P; Sastre-Garau X; Laé M; Pierga JY; Reyal F
    PLoS One; 2016; 11(7):e0159123. PubMed ID: 27388624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.